| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |